GRP
NAMS icon

Global Retirement Partners’s NewAmsterdam Pharma NAMS Stock Holding History

Global Retirement Partners’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.15K Buy
+270
New +$8.9K ﹤0.01% 3441
2025
Q4 		$9.47K Buy
+270
New +$9.83K ﹤0.01% 3178
2024
Q4 		– Sell
-91
Closed -$1.51K – 3742
2024
Q3 		$1.51K Sell
91
-302
-77% -$5.22K ﹤0.01% 3030
2024
Q2 		$7.55K Buy
+393
New +$7.88K ﹤0.01% 2437

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Global Retirement Partners's NAMS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 270 shares worth $9.15K. The stake represents ﹤0.01% of the portfolio and ranks #3441 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in NAMS as recently as Q4 2025.

Global Retirement Partners first reported a position in NAMS in Q2 2024 and has held it in 4 quarters since. The position peaked at $9.47K in Q4 2025. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Global Retirement Partners held 270 shares of NewAmsterdam Pharma worth $9.15K as of Q2 2026.
  • NewAmsterdam Pharma was a new Global Retirement Partners position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3441 holding.
  • Global Retirement Partners first reported a position in NewAmsterdam Pharma in Q2 2024 and has held it in 4 quarters since.
  • Global Retirement Partners's NewAmsterdam Pharma position peaked at $9.47K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.